Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Xabi Murgia"'
Autor:
Hanzey Yasar, Alexander Biehl, Chiara De Rossi, Marcus Koch, Xabi Murgia, Brigitta Loretz, Claus-Michael Lehr
Publikováno v:
Journal of Nanobiotechnology, Vol 16, Iss 1, Pp 1-19 (2018)
Abstract Background Messenger RNA (mRNA) has gained remarkable attention as an alternative to DNA-based therapies in biomedical research. A variety of biodegradable nanoparticles (NPs) has been developed including lipid-based and polymer-based system
Externí odkaz:
https://doaj.org/article/a1679658956f434ea859878d25c8507f
Autor:
Xiaojing Guo, Siwei Luo, Davide Amidani, Claudio Rivetti, Giuseppe Pieraccini, Barbara Pioselli, Silvia Catinella, Xabi Murgia, Fabrizio Salomone, Yaling Xu, Ying Dong, Bo Sun
Publikováno v:
PLoS ONE, Vol 15, Iss 3, p e0230229 (2020)
Poractant alfa and Calsurf are two natural surfactants widely used in China for the treatment of neonatal respiratory distress syndrome, which are extracted from porcine and calf lungs, respectively. The purpose of this experimental study was to comp
Externí odkaz:
https://doaj.org/article/210f3f62b99b4b4aa3fe9c992c866f0b
Autor:
Francesca Ricci, Costanza Casiraghi, Matteo Storti, Francesco D'Alò, Chiara Catozzi, Roberta Ciccimarra, Francesca Ravanetti, Antonio Cacchioli, Gino Villetti, Maurizio Civelli, Xabi Murgia, Virgilio Carnielli, Fabrizio Salomone
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0200542 (2018)
Nasal intermittent positive pressure ventilation (NIPPV) holds great potential as a primary ventilation support method for Respiratory Distress Syndrome (RDS). The use of NIPPV may also be of great value combined with minimally invasive surfactant de
Externí odkaz:
https://doaj.org/article/705a41e1fa184538aad96d5e5af29d35
Autor:
Maurizio Civelli, Virgilio P. Carnielli, Fabrizio Salomone, Xabi Murgia, Daniele De Luca, Barbara Pioselli, Silvia Catinella, Davide Amidani, Francesco Amadei, Gino Villetti, Elisa Sgarbi, Giuseppe Mazzola
Publikováno v:
Current Medicinal Chemistry. 29:526-590
Pulmonary surfactant is a complex lipoprotein mixture secreted into the alveolar lumen by type 2 pneumocytes, which is composed by tens of different lipids (approximately 90% of its entire mass) and surfactant proteins (approximately 10% of the mass)
Autor:
Federico Bianco, Doris Cunha-Goncalves, Valeria Perez-de-Sa, Anders Nord, Xabi Murgia, Martin Schlun, Francesca Ricci, Rikard Linner, Fabrizio Salomone
Publikováno v:
Pediatric pulmonologyREFERENCES. 55(2)
Background: Nasal continuous positive airway pressure support (nCPAP) is the standard of care for prematurely born infants at risk of neonatal respiratory distress syndrome (nRDS). However, nasal intermittent positive pressure ventilation (NIPPV) may
Autor:
Xabi Murgia, Ulrich F. Schaefer, Cristiane de Souza Carvalho-Wodarz, Sarah Gordon, Hanzey Yasar, Konrad Schwarzkopf, Claus-Michael Lehr, Brigitta Loretz
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 118:79-88
The airway epithelium together with the mucus layer coating it forms a protective system that efficiently filters and removes potentially harmful particles contained in inhaled air. The same mechanism, however, serves to entrap particulate drug carri
Autor:
Jaan Toelen, Costanza Casiraghi, Andre Gie, Julio Jimenez, Greetje Vande Velde, Michel Koole, Francesca Ricci, Thomas Salaets, Margo Aertgeerts, Xabi Murgia, Fabrizio Salomone, Karel Allegaert, Olivier Gheysens, Gino Villetti, Jan Deprest
Publikováno v:
American Journal of Physiology-Lung Cellular and Molecular Physiology, 316(4), L589-L597. American Physiological Society
L589
L597
American journal of physiology. Lung cellular and molecular physiology
United States
L589
L597
American journal of physiology. Lung cellular and molecular physiology
United States
Recent clinical trials in newborns have successfully used surfactant as a drug carrier for an active compound, to minimize systemic exposure. To investigate the translational potential of surfactant-compound mixtures and other local therapeutics, a r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9134c5733ee423a6d79e9d0513c3249
https://lirias.kuleuven.be/handle/123456789/633813
https://lirias.kuleuven.be/handle/123456789/633813
Autor:
Claus-Michael Lehr, Xabi Murgia, Hanzey Yasar, Marcus Koch, Alexander Biehl, Chiara De Rossi, Brigitta Loretz
Publikováno v:
Journal of nanobiotechnology
Journal of Nanobiotechnology, Vol 16, Iss 1, Pp 1-19 (2018)
Journal of Nanobiotechnology, Vol 16, Iss 1, Pp 1-19 (2018)
Background Messenger RNA (mRNA) has gained remarkable attention as an alternative to DNA-based therapies in biomedical research. A variety of biodegradable nanoparticles (NPs) has been developed including lipid-based and polymer-based systems for mRN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3187523760f8359f04d3409085bc605c
Autor:
Matteo Storti, Costanza Casiraghi, Francesca Ravanetti, Fabrizio Salomone, Xabi Murgia, Maurizio Civelli, Virgilio P. Carnielli, Francesca Ricci, Gino Villetti, Francesco D’Alò, Roberta Ciccimarra, Chiara Catozzi, Antonio Cacchioli
Publikováno v:
PLoS ONE
PloS one
PLoS ONE, Vol 13, Iss 7, p e0200542 (2018)
PloS one
PLoS ONE, Vol 13, Iss 7, p e0200542 (2018)
Nasal intermittent positive pressure ventilation (NIPPV) holds great potential as a primary ventilation support method for Respiratory Distress Syndrome (RDS). The use of NIPPV may also be of great value combined with minimally invasive surfactant de
Publikováno v:
European Journal of Nanomedicine. 6
The pulmonary route offers an exceptional, non-invasive administration site for drug delivery. The principal characteristics that make the lungs an appealing route for drug administration include a large surface for drug dispersion (approximately 100